Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Spits

Showing results (161-170 of 167) with videos related to

Pageof 17
Sort By:
You have reached the last page of results.This site can display upto 167 results.
Science (New York, N.Y.)|November 9, 1990
Expression of interleukin-10 activity by Epstein-Barr virus protein BCRF1D H Hsu, R de Waal Malefyt, D F Fiorentino, et al.
Nature Communications|October 7, 2021
CD127+ CD94+ innate lymphoid cells expressing granulysin and perforin are expanded in patients with Crohn's diseaseL Krabbendam, B A Heesters, C M A Kradolfer, et al.
Blood|June 14, 2000
A combination of anti-CD3 and anti-CD7 ricin A-immunotoxins for the in vivo treatment of acute graft versus host diseaseY V van Oosterhout, L van Emst, A V Schattenberg, et al.
Leukemia|December 9, 2014
L-type amino-acid transporter 1 (LAT1): a therapeutic target supporting growth and survival of T-cell lymphoblastic lymphoma/T-cell acute lymphoblastic leukemiaC Rosilio, M Nebout, V Imbert, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 22, 2001
Human thymic stromal lymphopoietin preferentially stimulates myeloid cellsP A Reche, V Soumelis, D M Gorman, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 15, 1997
Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteinsA H Schinkel, U Mayer, E Wagenaar, et al.
Cancer Immunology, Immunotherapy : CII|November 23, 2020
Melanoma cells can be eliminated by sialylated CD43 × CD3 bispecific T cell engager formats in vitro and in vivoG de Jong, L Bartels, M Kedde, et al.
Pageof 17

Showing results (161-170 of 167) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 167 results.
Science (New York, N.Y.)|November 9, 1990
Expression of interleukin-10 activity by Epstein-Barr virus protein BCRF1D H Hsu, R de Waal Malefyt, D F Fiorentino, et al.
Nature Communications|October 7, 2021
CD127+ CD94+ innate lymphoid cells expressing granulysin and perforin are expanded in patients with Crohn's diseaseL Krabbendam, B A Heesters, C M A Kradolfer, et al.
Blood|June 14, 2000
A combination of anti-CD3 and anti-CD7 ricin A-immunotoxins for the in vivo treatment of acute graft versus host diseaseY V van Oosterhout, L van Emst, A V Schattenberg, et al.
Leukemia|December 9, 2014
L-type amino-acid transporter 1 (LAT1): a therapeutic target supporting growth and survival of T-cell lymphoblastic lymphoma/T-cell acute lymphoblastic leukemiaC Rosilio, M Nebout, V Imbert, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 22, 2001
Human thymic stromal lymphopoietin preferentially stimulates myeloid cellsP A Reche, V Soumelis, D M Gorman, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 15, 1997
Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteinsA H Schinkel, U Mayer, E Wagenaar, et al.
Cancer Immunology, Immunotherapy : CII|November 23, 2020
Melanoma cells can be eliminated by sialylated CD43 × CD3 bispecific T cell engager formats in vitro and in vivoG de Jong, L Bartels, M Kedde, et al.
Pageof 17